Pharmacovigilance and drug safety career pathway
Pharmacovigilance and drug safety is the functional family responsible for collecting, assessing, documenting and reporting adverse events and safety signals, both during clinical trials and after a product reaches the market. The work is time-bound, heavily documented and directly tied to participant and patient protection.
Where this pathway sits in drug development
Safety runs the entire length of development and continues after approval. During trials it processes events reported from sites and assesses expectedness and seriousness; post-marketing it handles case intake at scale and contributes to ongoing benefit-risk assessment.
Common roles and levels
- Entry
Drug Safety Associate
Case intake, triage, data entry and follow-up on incomplete reports.
- Mid
Pharmacovigilance Specialist
Case assessment, narrative writing and regulatory reporting timelines.
- Senior
Senior PV Scientist
Signal detection support, aggregate reports and complex case review.
- Senior
PV Operations or Compliance Lead
Process, quality of case handling and reporting-compliance oversight.
Titles and level bands differ between organizations and regions. Treat this as a map of the family, not a set of employer requirements.
Who this pathway may suit
- Pharmacists, nurses and clinicians comfortable assessing clinical narratives
- Coordinators who already handle adverse-event documentation at a site
- Life-sciences graduates who write precisely and work well against deadlines
- People from other regulated case-processing environments with strong triage habits
Capability employers commonly look for
- Recognizing when an event is serious and what that changes about handling it
- Assessing expectedness against reference safety information
- Writing a case narrative that a reviewer can follow without asking questions
- Working reporting clocks correctly, including when the clock actually starts
- Chasing missing information without losing the thread of the case
- Spotting when several individually unremarkable cases are worth flagging
Evidence you can build
- A reviewed adverse-event triage exercise showing how you classified and why
- A written case narrative critiqued for accuracy, completeness and readability
- A worked scenario on reporting timelines where the start point is ambiguous
- A structured account of safety documentation you handle in a current role, reviewed against written criteria
Practice feedback is developmental. Work only becomes human-reviewed evidence once a person has assessed it against written criteria.
Entry and progression routes
Getting in
Case-processing associate roles at a CRO, a safety vendor or a sponsor are the usual entry point. Clinical backgrounds help with assessment; documentation backgrounds help with throughput. Illustrative only.
Moving within
People often move from intake and triage into assessment and narrative work, then into aggregate reporting or signal support depending on interest.
Moving up
Senior routes split between scientific depth, such as signal and benefit-risk work, and operational depth, such as compliance and process ownership.
These routes are illustrative. Completing learning or reviewed work does not guarantee eligibility, an interview, an offer or progression, and each employer sets its own requirements.
Role guides in this pathway
Practice this pathway's work for free
- Pharmacovigilance Associate
Pharmacovigilance Case Processing Challenge
An incoming case with a hospitalisation, a contested reporting clock, and a suspected duplicate.
Start the challenge
How BORAKA supports this pathway
- Pharmacovigilance Essentials
Self-paced course on case intake, assessment and reporting timelines.
Go - Case processing challenge
Free practice on a safety case, scored against written criteria before you pay for anything.
Go - Role Readiness Scan
A free structured read of what your target role expects and what to do in the next 30 days.
Go - Career Services
Career strategy, positioning and interview preparation once the target role is clear.
Go
Frequently asked questions
What is the difference between clinical trial safety and post-marketing safety?
Trial safety handles events reported by investigators for participants in a study, against a defined protocol and reference safety information. Post-marketing safety handles reports from a much wider and less controlled population, usually at far higher volume.
Do I need to be a clinician to work in pharmacovigilance?
Not universally. Clinical training is common and useful for assessment work, but many case-processing and operational roles are filled by life-sciences graduates and experienced documentation professionals. Employers set their own requirements.
What does SUSAR mean?
A suspected unexpected serious adverse reaction: an event that is serious, suspected to be related to the investigational product, and not already described in the reference safety information. Handling these correctly and on time is a core part of the work.
Is drug safety work repetitive?
Case processing has a defined rhythm, and the volume can be high. The judgment, though, is not routine: seriousness, causality and expectedness decisions are where the difficulty and the skill sit.
Can I move into safety from a coordinator role?
It is a recognized move, especially for coordinators who already document adverse events and understand how a site reports them. Reviewed triage and narrative work is a practical way to show the assessment side.
Take the next step in this pathway
Start with structured learning, or try the free challenge first and see how the work reads before you commit to anything.